Concepedia

Author

Lene Jensen

Novo Nordisk (Denmark)ORCID

Also Known As

Jensen, Line Methea, L. B. Jensen, L. Jensen, Lars Juhl Jensen, Lene Jensen

14

Publications

1K

Citations

9

H-Index

6

Concepts

All Affiliations

Novo Nordisk (Denmark)Medical University of GrazUniversity of SheffieldNovo Nordisk (United States)
LJ

About

Lene Jensen is an author at Novo Nordisk (Denmark) specializing in clinical pharmacology, pharmacotherapy, and endocrinology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

503

2

Endocrinology

1

1

503

3

Pharmacology

1

1

503

4

Clinical Pharmacology

1

1

503

5

Physiology

1

1

503

Lene Jensen

×

9

Publications

1K

Citations

9

H-Index

YearCitations

The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men

Henrik Agersø, Lene Jensen, B. Elbrønd,

Diabetologia

2002

503

Absorption, metabolism and excretion of the GLP-1 analogue semaglutide in humans and nonclinical species

Lene Jensen, Hans Helleberg, Ad F. Roffel,

European Journal of Pharmaceutical Sciences

2017

161

Semaglutide, a once‐weekly human GLP‐1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel

Christoph Kapitza, Leszek Nosek, Lene Jensen,

The Journal of Clinical Pharmacology

2014

157

Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment

Lene Jensen, Viera Kupčová, Gerhard Arold,

Diabetes Obesity and Metabolism

2017

64

Counter‐regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo‐controlled, double‐blind, crossover trial

Thomas R. Pieber, Sigrid Deller, Stefan Korsatko,

Diabetes Obesity and Metabolism

2015

43

Effect of once‐weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo‐controlled, double‐blind, crossover trial

Stefan Korsatko, Lene Jensen, Martina Brunner,

Diabetes Obesity and Metabolism

2018

27

A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects

Ippei Ikushima, Lene Jensen, Anne Flint,

Advances in Therapy

2018

26

Multiple doses of pegylated long‐acting growth hormone are well tolerated in healthy male volunteers and possess a potential once‐weekly treatment profile

Michael Højby Rasmussen, Lene Jensen, Thomas W. Anderson,

Clinical Endocrinology

2010

17

Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus

Julia K. Mader, Lene Jensen, Steen H. Ingwersen,

Clinical Pharmacokinetics

2016

14

Page 1